metyrapone has been researched along with Graft-Versus-Host Disease in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T | 2 |
| Shimada, S | 1 |
| Osako, R | 1 |
| Nomura, M | 1 |
2 other studies available for metyrapone and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Chronic runt disease in rats: clinical and pathologic studies.
Topics: Animals; Body Weight; Bone Marrow; Graft vs Host Disease; Injections, Intraperitoneal; Lymph Nodes; | 1969 |
Amelioration of Runt disease in rats by metopirone.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Animals; Graft vs Host Disease; Hybridization, Genetic; Leuk | 1970 |